Hemodynamic and histomorphometric characteristics of dilated cardiomyopathy of Syrian hamsters (Bio TO-2 strain)

被引:23
作者
Goineau, S
Pape, D
Guillo, P
Ramée, MP
Bellissant, E
机构
[1] Fac Med Rennes, Lab Pharmacol Expt & Clin, UPRES EA 1263, F-35043 Rennes, France
[2] Hop Pontchaillou, Anat Pathol B Lab, F-35033 Rennes, France
关键词
cardiomyopathy; heart failure; regional blood flow; remodeling;
D O I
10.1139/cjpp-79-4-329
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The natural history of the disease of the dilated strain Bio TO-2 of cardiomyopathic hamsters (CMH) is not totally characterized. We investigated its hemodynamic and histomorphometric characteristics at 140, 180, 220, 260, and 300 days of age. Forty CMH and 40 controls were investigated (8 at each stage). Mean arterial pressure (MAP, carotid artery catheter) and cardiac output and femoral blood flow (CO, FBF, transit time method) were measured in anesthetized animals. Systemic (SVR) and femoral (FVR) vascular resistances were calculated. Atria, left and right ventricles (LV, RV), lungs, and liver were weighed. LV cavity area, LV and RV wall thicknesses and collagen densities were determined (computer-assisted image analyzer). Pulmonary and hepatic congestion were assessed (arbitrary scales). Compared with controls, MAP, CO and FBF were significantly lower in CMH throughout the study (on average: -22%, -34%, -33%, respectively), FVR was significantly increased (+15%), but SVR was not significantly modified. Concerning histomorphometric characteristics, differences between groups significantly increased with age for most variables: at 300 days, atria (+292%), RV (+13%), lungs (+44%), and liver (+23%) weights, LV cavity area (+130%), LV (+364%) and RV (+181%) collagen densities were significantly increased in CMH vs controls, whereas LV (-40%) and RV (-23%) wall thicknesses were significantly decreased. At 260 and 300 days, CMH showed significant pulmonary congestion without hepatic alteration. Bio TO-2 CMH progressively develop an alteration of cardiac function leading to decreased MAP and musculo-cutaneous blood flow associated with cardiac remodeling including atria hypertrophy and LV dilation, wall thinning and a rise in collagen density.
引用
收藏
页码:329 / 337
页数:9
相关论文
共 36 条
[1]   SARCOPLASMIC-RETICULUM CA2+ PUMPS IN HEART AND DIAPHRAGM OF CARDIOMYOPATHIC HAMSTER - EFFECTS OF PERINDOPRIL [J].
ANGER, M ;
LAMBERT, F ;
CHEMLA, D ;
DESCHE, P ;
SCALBERT, E ;
LOMPRE, AM ;
LECARPENTIER, Y .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 268 (05) :H1947-H1953
[2]  
ARAKI T, 1994, CARDIOMYOPATHIC HEART, P137
[3]   COMPARISONS OF HEMODYNAMICS THROUGHOUT THE LIFE-SPAN OF THE BIO-14.6 CARDIOMYOPATHIC WITH THE F1B NORMAL HAMSTER [J].
AWAD, SS ;
WELTY, JD .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-PHYSIOLOGY, 1990, 97 (04) :487-491
[4]   SPONTANEOUS HEREDITARY MYOCARDIAL DEGENERATION AND CONGESTIVE HEART FAILURE IN A STRAIN OF SYRIAN HAMSTERS [J].
BAJUSZ, E ;
BAKER, JR ;
NIXON, CW ;
HOMBURGER, F .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1969, 156 (A1) :105-+
[5]   EFFECTS OF EARLY AND LATE THERAPY WITH PERINDOPRIL ON SURVIVAL AND MYOCARDIAL INOTROPIC STATE IN EXPERIMENTAL DILATED CARDIOMYOPATHY [J].
CHEMLA, D ;
SCALBERT, E ;
DESCHE, P ;
LEREBOURS, G ;
SUARD, I ;
LECARPENTIER, Y .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 24 (01) :151-157
[6]   Effect of trimetazidine and verapamil on the cardiomyopathic hamster myosin phenotype [J].
D'hahan, N ;
Taouil, K ;
Janmot, C ;
Morel, JE .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 (04) :611-616
[7]   CELLULAR MECHANISMS OF CAPTOPRIL-INDUCED MATRIX REMODELING IN SYRIAN-HAMSTER CARDIOMYOPATHY [J].
DAVISON, G ;
HALL, CS ;
MILLER, JG ;
SCOTT, M ;
WICKLINE, SA .
CIRCULATION, 1994, 90 (03) :1334-1342
[8]   Long-term therapy with trimetazidine in cardiomyopathic Syrian hamster BIO 14:6 [J].
Dhahan, N ;
Taouil, K ;
Dassouli, A ;
Morel, JE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 328 (2-3) :163-174
[9]   Atrial natriuretic factor (ANF) and ANF receptor C gene expression and localization in the respiratory system: Effects induced by hypoxia and hemodynamic overload [J].
DiNardo, P ;
Minieri, M ;
Sampaolesi, M ;
Carbone, A ;
Loreni, F ;
Samuel, JL ;
Lauro, R .
ENDOCRINOLOGY, 1996, 137 (10) :4339-4350
[10]  
GERTZ EW, 1972, PROG EXP TUMOR RES, V16, P242